Back to search

Article

A multimodal approach of microglial CSF1R inhibition and GENUS provides therapeutic effects in Alzheimer’s disease mice

2025-04-28

Abstract excerpt

<h4>Summary</h4> The CSF1R inhibitor PLX3397, an FDA-approved treatment for a rare cancer, has been shown to reduce microglia count, lower inflammation, and increase synaptic markers in mouse models of Alzheimer’s disease (AD). However, the effects of PLX3397 on neural function in AD remain largely unknown. Here, we characterized the effects of PLX3397 treatment in 5xFAD mice. While PLX3397 increased synaptic den...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
89de91fa-f2b9-58e3-8f42-2a6645c022ae
DOI
10.1101/2025.04.27.648471
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A multimodal approach of microglial CSF1R inhibition and GENUS provides therapeutic effects in Alzheimer’s disease miceDOI 10.1101/2025.04.27.648471
Select a neighboring publication to make it the new centre.